Cytoo
CYTOO is a biotech company focused on muscle health. Its MyoScreen™ platform models key features of inherited and acquired muscle diseases, enabling in vitro screening of relevant phenotypes, biomarkers and pathways. Combined with expertise in assay development and AI-driven image analysis, MyoScreen supports drug development across the pipeline, including disease modeling, primary and secondary screening to candidate characterization and potency assays for batch release. MyoScreen has helped advance drugs into trials during over 60+ industry partner projects. To support sponsor’s CMC activities, CYTOO is setting up a GMP facility, operational by end 2025.
